Clinical Trial Update: Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pitavastatin 4 mg to pravastatin 40 mg in adults with primary hyperlipidemia or mixed dyslipidemia has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Pitavastatin (Pitavastatin)
• Pravastatin (pravastatin)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Primary Dyslipidemia, Mixed Dyslipidemia | Phase 4 | Status: COMPLETED | Results posted: 2012-04-30